Wealth Enhancement Advisory Services »

Ultragenyx Pharmaceutical shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Ultragenyx Pharmaceutical (RARE) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Ultragenyx Pharmaceutical

Tip: Access up to 7 years of quarterly data

All positions including Ultragenyx Pharmaceutical held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ultragenyx Pharmaceutical by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2024-03-31 $298k 6.4k 46.69
2023-12-31 $295k 6.2k 47.82

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Msci Intl Moment (IMTM)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Schwab Strategic Tr Schwb Fdt Int Lg (FNDF)
Alps Etf Tr Smith Core Plus (SMTH)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Smlc (DWAS)
Amazon (AMZN)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
American Centy Etf Tr Us Large Cap Vlu (AVLV)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Ultragenyx Pharmaceutical

Vanguard Group
Wellington Management Company
T. Rowe Price Associates
Federated Investors
ClearBridge Advisors
Alliancebernstein
Marshall Wace
Baker Bros. Advisors
Deutsche Bank Aktiengesellschaft
Bank of New York Mellon
Avidity Partners Management
Norges Bank Investment Management
First Light Asset Management
Jacobs Levy Equity Management
Dr. Jeffrey R. Jay, M.D.

View all funds holding Ultragenyx Pharmaceutical